full_colour.png
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 29, 2024 07:00 ET | GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...
FDA Clears Magstim TMS Horizon 3.0 with StimGuide Pro Treatment for Patients with Depression, Obsessive Compulsive Disorder, Anxious Depression
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET | Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
22157.jpg
United Kingdom Mental Health Apps Market Size, Share & Trends Analysis Report 2023-2030 Featuring Mindspace, Calm, Headspace, Youper, MoodMission, and Sanvello Health
January 24, 2024 10:27 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "U.K. Mental Health Apps Market Size, Share & Trends Analysis Report By Platform (Android, iOS), By Application (Depression & Anxiety...
full_colour.png
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
January 18, 2024 16:30 ET | GH Research PLC
DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
MindFit Toolkit - Mental Wellness for Men by Canadian Men's Health Foundation
Canadian Men’s Health Foundation reports that more men are addressing stress, anxiety and depression
January 18, 2024 08:00 ET | Canadian Men's Health Foundation
CMHF is helping more men tackle chronic stress, anxiety and depression with the MindFit Toolkit, presented by TELUS Health.
logo.png
Nexstim Agrees on a Strategic Investment into a Management Services Organization of a New Jersey Based Clinic Providing Treatments for Depression Patients
January 04, 2024 02:00 ET | Nexstim Oyj
Press release, Helsinki, 4 January 2024 at 9 AM (EET) Nexstim Agrees on a Strategic Investment into a Management Services Organization of a New Jersey Based Clinic Providing Treatments for Depression...
Healis Therapeutics Announces Supply Agreement with CKD Bio to develop CKDB-501 for neuropsychiatric indications
January 02, 2024 08:00 ET | Healis Therapeutics
NEWPORT BEACH, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Healis Therapeutics, a privately held biotechnology company, today announced it has entered into a supply agreement with CKD Bio Corporation...
Emergen logo.png
Global Deep Brain Stimulation Market Size to Reach USD 4.27 Billion in 2032 | Emergen Research
December 12, 2023 07:31 ET | Emergen Research
Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The global Deep Brain Stimulation (DBS) market, valued at USD 1.70 Billion in 2022, is projected to witness a robust revenue Compound Annual Growth Rate...
Helping Children and
Helping Children and Adolescents with Emotional Problems: Free Webinar for Parents and Educators from the Brain & Behavior Research Foundation
November 16, 2023 13:00 ET | Brain & Behavior Research Foundation
New York, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Children’s mental health is a major concern and improving the potential for early intervention is essential. The Brain & Behavior Research Foundation...
Global Maternal Mental Health Market
Maternal Mental Health Market Size, Share & Trends Analysis Report 2023-2030: Rise In Awareness Programs and Efforts to Improve Practices Around Maternal Mental Healthcare
November 14, 2023 09:23 ET | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia), By Therapy...